Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Qurat Ul Ain, Kamili"'
Autor:
Daria Lie, Qurat Ul Ain Kamili, Robert W. Sugerman, Joanna G. Rolen, Dena M. Pence, Richard L. Wasserman
Publikováno v:
Journal of Allergy and Clinical Immunology. 145:AB76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f5869309d8157def732e6dc87f1569e
https://doi.org/10.1016/j.jaci.2019.12.663
https://doi.org/10.1016/j.jaci.2019.12.663
Autor:
Qurat Ul Ain Kamili, Dena M. Pence, Daria Lie, Robert W. Sugerman, Joanna G. Rolen, Richard L. Wasserman
Publikováno v:
Journal of Allergy and Clinical Immunology. 145:AB70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b950a26ab98f86b47aa0f4cd61d4d4f3
https://doi.org/10.1016/j.jaci.2019.12.644
https://doi.org/10.1016/j.jaci.2019.12.644
Autor:
Morley A. Herbert, Robert W. Sugerman, Joanna G. Rolen, Qurat Ul Ain Kamili, Angela R. Hague, Richard L. Wasserman, Deana M. Pence
Publikováno v:
Journal of Allergy and Clinical Immunology. 143:AB275
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb7894ece655f184c2de07f278f5e9d9
https://doi.org/10.1016/j.jaci.2018.12.841
https://doi.org/10.1016/j.jaci.2018.12.841
Autor:
Morley A. Herbert, Dena M. Pence, Qurat Ul Ain Kamili, Robert W. Sugerman, Richard L. Wasserman, Angela R. Hague, Joanna G. Rolen
Publikováno v:
Journal of Allergy and Clinical Immunology. 141:AB258
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11b1382e18186a007db55e39df91b685
https://doi.org/10.1016/j.jaci.2017.12.819
https://doi.org/10.1016/j.jaci.2017.12.819
Autor:
Angela R. Hague, Joanna G. Rolen, Robert W. Sugerman, Qurat Ul Ain Kamili, Richard L. Wasserman, Dena M. Pence
Publikováno v:
Journal of Allergy and Clinical Immunology. 141:AB241
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::812ffad5ec213706b92f48c3b413903d
https://doi.org/10.1016/j.jaci.2017.12.763
https://doi.org/10.1016/j.jaci.2017.12.763
Autor:
Qurat ul Ain Kamili, Alan Menter
Publikováno v:
Psoriasis Forum. :8-14
Psoriasis and psoriatic arthritis are the result of a complex interaction of genetic, immunological and environmental factors. The role of genetics is evident by various population-based studies, family-based studies and candidate gene studies both w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b03dd1881d35ad8aaf3d0bc7de662ee8
https://doi.org/10.1177/247553030915a00102
https://doi.org/10.1177/247553030915a00102
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 10:E14-E16
Lymphomas have been associated with immunodeficiency disorders, including those acquired secondary to the use of immunosuppressants for autoimmune disorders and for the prevention of graft rejection. Biologic agents have also been associated with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4daeb38e95ffbf4e258ef5e3a5660b1e
https://doi.org/10.3816/clml.2010.n.011
https://doi.org/10.3816/clml.2010.n.011
Publikováno v:
Journal of medical virology. 83(11)
Recently, a study of patients with rheumatoid arthritis who developed herpes zoster while taking a tumor necrosis factor (TNF)-α inhibitor reported a decreased incidence of postherpetic neuralgia. The objective of this study was to investigate wheth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e13a07166315a443792afa1e81f4371
https://pubmed.ncbi.nlm.nih.gov/21915882
https://pubmed.ncbi.nlm.nih.gov/21915882
Publikováno v:
Journal of drugs in dermatology : JDD. 10(5)
Infliximab is a chimeric monoclonal antibody, which acts by binding to both the soluble and membrane-bound tumor necrosis factor-?. In clinical practice, it is used as either monotherapy or in combination with other systemic therapies, particularly m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a49d9395a66adec0dca02b5c2e6b8ff
https://pubmed.ncbi.nlm.nih.gov/21533302
https://pubmed.ncbi.nlm.nih.gov/21533302
Autor:
Qurat ul Ain, Kamili, Alan, Menter
Publikováno v:
Journal of drugs in dermatology : JDD. 9(1)
Infliximab is a chimeric monoclonal antibody to TNF-alpha which acts on both the soluble and transmembrane forms of TNF-alpha. It has been used successfully for the treatment of psoriasis and psoriatic arthritis, rheumatoid arthritis, Crohn's disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5192ec3956ca73598d132928ef8d9a1d
https://pubmed.ncbi.nlm.nih.gov/20120426
https://pubmed.ncbi.nlm.nih.gov/20120426